Full Text
A Cost-Effectiveness Analysis of Commonly Used Biologic Drugs for the Treatment of Moderate-To-Severe Psoriasis in the United States

Abstract

Authors

JJ Wu SR Feldman S Rastogi B Menges M Lingohr-Smith J Lin

Back to Volume 21, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×